You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -113.2% | -69.2% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -2.2 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 4.3 | 3.6 |
| Price / Book value | 2.4 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 8.0% | -0.9% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -49.6% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | n/a | -17.58 | -15.42p | -12.4 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 0.01 | -18.62 | -12.54p | -13.9 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 9.43 | -23.46 | -12.54p | -14.9 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 25.16 | -30.34 | -14.48p | -9.9 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | 27.17 | -30.98 | -14.48p | -1.7 | 0.0 | n/a | n/a | 0.0% |
| Creo Medical gets US FDA clearance for Speedboat UltraSlim Sharecast News | 01 Nov |
|---|---|
| Creo Medical accelerating EU launch of Speedboat UltraSlim Sharecast News | 25 Oct |
| Creo Medical's 'Speedboat Inject' used for first time in Europe Sharecast News | 26 Jun |
| Capital Markets Day | 07-Nov-23 07:00 |
|---|---|
| Speedboat® UltraSlim: US FDA Clearance | 01-Nov-23 07:01 |
| SB UltraSlim: EU launch accelerated by 18 months | 25-Oct-23 07:00 |
| Change of Nominated Adviser and Joint Broker | 17-Oct-23 00:00 |
| Half-year Report | 12-Sep-23 14:29 |